Oxycodone
- Generic Name
- Oxycodone
- Brand Names
- Endocet, Endodan Reformulated May 2009, Nalocet, Oxaydo, Oxy.IR, Oxycontin, Oxyneo, Percocet, Prolate, Rivacocet, Roxicet, Roxicodone, Roxybond, Targin, Targiniq, Xolox, Xtampza
- Drug Type
- Small Molecule
- Chemical Formula
- C18H21NO4
- CAS Number
- 76-42-6
- Unique Ingredient Identifier
- CD35PMG570
- Background
Oxycodone is a semisynthetic opioid analgesic derived from thebaine in Germany in 1917. It is currently indicated as an immediate release product for moderate to severe pain and as an extended release product for chronic moderate to severe pain requiring continuous opioid analgesics for an extended period. The first oxycodone containing product, Percodan, wa...
- Indication
Oxycodone is indicated for the treatment of moderate to severe pain. There is also an extended release formulation indicated for chronic moderate to severe pain requiring continuous opioid analgesics for an extended period.
- Associated Conditions
- Severe Acute Pain, Severe Pain, Severe, Chronic Pain, Acute, moderate Pain, Chronic, moderate Pain
- Associated Therapies
- -
Educational Video on Pain Management and Subsequent Opioid Use After Cesarean Delivery
- Conditions
- Interventions
- First Posted Date
- 2019-05-22
- Last Posted Date
- 2021-04-01
- Lead Sponsor
- Medstar Health Research Institute
- Target Recruit Count
- 48
- Registration Number
- NCT03959969
- Locations
- 🇺🇸
Washington Hospital Center, Washington, District of Columbia, United States
Neurobehavioral Mechanisms of Choice in Opioid Use Disorder
- First Posted Date
- 2019-05-22
- Last Posted Date
- 2024-01-12
- Lead Sponsor
- Joshua A. Lile, Ph.D.
- Target Recruit Count
- 31
- Registration Number
- NCT03958474
- Locations
- 🇺🇸
Laboratory of Human Behavioral Pharmacology, Lexington, Kentucky, United States
Reduction of Opioid Dose Using Conditioning & Open-Label Placebo (COLP) in Patients With Spinal Cord Injury, Polytrauma and Burn Injury
- Conditions
- Interventions
- First Posted Date
- 2019-04-08
- Last Posted Date
- 2022-05-17
- Lead Sponsor
- Spaulding Rehabilitation Hospital
- Target Recruit Count
- 30
- Registration Number
- NCT03906721
- Locations
- 🇺🇸
Spaulding Rehabilitation Hospital, Charlestown, Massachusetts, United States
Towards Predicting the Analgesic Response to Ibuprofen Following Third-molar Extraction
- Conditions
- Interventions
- First Posted Date
- 2019-03-28
- Last Posted Date
- 2022-04-19
- Lead Sponsor
- University of Pennsylvania
- Target Recruit Count
- 86
- Registration Number
- NCT03893175
- Locations
- 🇺🇸
Institute for Translational Medicine and Therapeutics (ITMAT), University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, United States
Study of Ketorolac Versus Opioid for Pain After Endoscopy
- First Posted Date
- 2019-03-25
- Last Posted Date
- 2021-08-26
- Lead Sponsor
- The Cleveland Clinic
- Target Recruit Count
- 81
- Registration Number
- NCT03888144
- Locations
- 🇺🇸
Cleveland Clinic Foundation, Cleveland, Ohio, United States
Efficacy of Opioid-limiting Pain Management Protocol in Men Undergoing Urethroplasty
- First Posted Date
- 2019-03-01
- Last Posted Date
- 2023-08-01
- Lead Sponsor
- University of Alabama at Birmingham
- Target Recruit Count
- 60
- Registration Number
- NCT03859024
- Locations
- 🇺🇸
University of Alabama of Birmingham, Birmingham, Alabama, United States
Trial Comparing a Multi-Modal Pain Protocol With and Without Opioids Following Total Joint Arthroplasty
- Conditions
- Interventions
- First Posted Date
- 2019-02-19
- Last Posted Date
- 2020-07-30
- Lead Sponsor
- Mayo Clinic
- Target Recruit Count
- 45
- Registration Number
- NCT03845881
- Locations
- 🇺🇸
Mayo Clinic in Florida, Jacksonville, Florida, United States
Post-Op Pain Control for Prophylactic Intramedullary Nailing.
- First Posted Date
- 2019-01-30
- Last Posted Date
- 2024-11-06
- Lead Sponsor
- St. Louis University
- Target Recruit Count
- 60
- Registration Number
- NCT03823534
- Locations
- 🇺🇸
Saint Louis University, Saint Louis, Missouri, United States
Multimodal Pain Therapy After Hernia Repair
- Conditions
- Interventions
- First Posted Date
- 2019-01-03
- Last Posted Date
- 2021-08-04
- Lead Sponsor
- Khashayar Vaziri
- Registration Number
- NCT03792295
- Locations
- 🇺🇸
George Washington University Hospital, Washington, District of Columbia, United States
Study in Subjects Undergoing Complete Abdominoplasty
- First Posted Date
- 2018-12-28
- Last Posted Date
- 2024-03-19
- Lead Sponsor
- Concentric Analgesics
- Target Recruit Count
- 54
- Registration Number
- NCT03789318
- Locations
- 🇺🇸
Lotus Clinical Research, LLC, Pasadena, California, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.